Webinar: Life Science Evidence Hubs
When: Wednesday 13th May 2020
Time: 4:00pm BST; 5:00pm CEST; 11:00am EDT; 8:00am PDT.
Duration: 40 minutes.
Making decisions with “disconnected” information is a critical issue that leads to inefficiency, productivity loss and compliance risk. Linguamatics NLP Evidence Hubs integrate and transform information from a variety of document streams into easy-to-consume dashboards, to enable evidence-led decision-making. Evidence Hubs can be developed for discovery, development, regulatory affairs, safety; with input data sources and output dashboards or alerts tailored as needed.
NLP text mining can extract the key facts, using relevant ontologies and focused queries, transforming data from different evidence streams into actionable intelligence for decision making. Linguamatics evidence hub offering enables you to identify, pinpoint, and extract information that’s usually unavailable or really hard to get to; synthesise across sources; and provide output for rapid decisions support.
What you will learn:
During the webinar we will touch on how Linguamatics NLP Evidence Hubs can reduce manual effort and provide business decision support across multiple areas including:
- Medical affairs
- Regulatory affairs
- Opportunity scouting
- And more!
Who should attend?
This webinar will be of interest to anyone who wants to understand more about the power of NLP to integrate diverse document streams and transform unstructured text into intelligence, either from the knowledge management perspective or research, development or commercial business area leads.
Jane Z. Reed, Director Life Science, Linguamatics
Jane Reed is Director of Life Science at Linguamatics. She is responsible for developing the strategic vision for Linguamatics’ growing product portfolio and business development in the life science domain. Jane has extensive experience in life science informatics. She worked for more than 15 years in vendor companies supplying data products, data integration and analysis, and consultancy to pharma and biotech—with roles at Instem, BioWisdom, Incyte, and Hexagen. Before moving into the life science industry, Jane worked in academia with post-docs in genetics and genomics.